{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:27:27Z","timestamp":1793978847671,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100025471","name":"Consejer\u00eda de Universidad, Investigaci\u00f3n e Innovaci\u00f3n, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["P21_00061"],"award-info":[{"award-number":["P21_00061"]}],"id":[{"id":"10.13039\/501100025471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006393","name":"Universidad de Granada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119225","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:06:32Z","timestamp":1786374392000},"page":"119225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of mitochondria-targeted isoquinolinium derivatives with dual fluorescence and anticancer activity against KRAS-mutant NSCLC"],"prefix":"10.1016","volume":"319","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0818-6959","authenticated-orcid":false,"given":"Iria","family":"Alonso-Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5776-7315","authenticated-orcid":false,"given":"Ana","family":"Conejo-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4720-6578","authenticated-orcid":false,"given":"Bel\u00e9n","family":"Rubio-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119225_bib1","doi-asserted-by":"crossref","first-page":"9794","DOI":"10.1039\/D1CS00017A","article-title":"Fluorescent kinase inhibitors as probes in cancer","volume":"50","author":"Usama","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2026.119225_bib2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jpha.2020.08.006","article-title":"Recent advances in construction of small molecule-based fluorophore-drug conjugates","volume":"10","author":"Lang","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.ejmech.2026.119225_bib3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3390\/biology11081135","article-title":"Intrinsically fluorescent anti-cancer drugs","volume":"11","author":"Kabir","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.ejmech.2026.119225_bib4","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.2174\/1568026620999200917154225","article-title":"An overview of privileged scaffold: quinolines and isoquinolines in medicinal chemistry as anticancer agents","volume":"20","author":"Mao","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119225_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/toxins16110489","article-title":"Antibacterial activity and antifungal activity of monomeric alkaloids","volume":"16","author":"Thawabteh","year":"2024","journal-title":"Toxins"},{"key":"10.1016\/j.ejmech.2026.119225_bib6","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.3390\/molecules28124797","article-title":"Research progress on neuroprotective effects of isoquinoline alkaloids","volume":"28","author":"Li","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119225_bib7","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.3390\/molecules24224070","article-title":"Synthesis and fluorescent properties of novel isoquinoline derivatives","volume":"24","author":"Balewski","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119225_bib8","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.3390\/molecules30244760","article-title":"Recent advances in synthetic isoquinoline-based derivatives in drug design","volume":"30","author":"Balewski","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119225_bib9","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1039\/D5TB00286A","article-title":"Synthesis of versatile fluorescent isoquinolinium salts and their applications","volume":"13","author":"Han","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejmech.2026.119225_bib10","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.bbabio.2008.03.029","article-title":"Targeting lipophilic cations to mitochondria","volume":"1777","author":"Murphy","year":"2008","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.ejmech.2026.119225_bib11","doi-asserted-by":"crossref","first-page":"R551","DOI":"10.1016\/j.cub.2006.06.054","article-title":"Mitochondria: more than just a powerhouse","volume":"16","author":"McBride","year":"2006","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejmech.2026.119225_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","article-title":"Mitochondria and cancer","volume":"166","author":"Vyas","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119225_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-025-02311-x","article-title":"Mitochondrial metabolism and cancer therapeutic innovation","volume":"10","author":"Du","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.119225_bib14","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.3390\/ijms21217941","article-title":"Mitocans revisited: mitochondrial targeting as efficient anti-cancer therapy","volume":"21","author":"Dong","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119225_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","article-title":"Mitochondrial metabolism as a target for cancer therapy","volume":"32","author":"Vasan","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2026.119225_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","article-title":"Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials","volume":"29","author":"Yap","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119225_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15384047.2022.2029132","article-title":"Feasibility and safety of targeting mitochondria for cancer therapy \u2013 preclinical characterization of gamitrinib, a first-in-class, mitochondrial-targeted small molecule Hsp90 inhibitor","volume":"23","author":"Hayat","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejmech.2026.119225_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231197957","article-title":"Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I\/Ib clinical trial","volume":"15","author":"Bielcikova","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ejmech.2026.119225_bib19","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2026.119225_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104554","article-title":"KRAS mutations in advanced non-small cell lung cancer: from biology to novel therapeutic strategies","volume":"205","author":"Liguori","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ejmech.2026.119225_bib21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(23)00221-0","article-title":"Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial","volume":"401","author":"de Langen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119225_bib22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(25)00866-9","article-title":"Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial","volume":"406","author":"Barlesi","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119225_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1704347","article-title":"Therapeutic strategies for KRAS G12C-mutant non-small cell lung cancer: from bench to bedside and beyond","volume":"16","author":"Huang","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119225_bib24","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.apsb.2022.10.023","article-title":"Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-Mutant lung cancer","volume":"13","author":"Feng","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119225_bib25","doi-asserted-by":"crossref","first-page":"8408","DOI":"10.1021\/acs.jmedchem.0c00754","article-title":"The most common functional groups in bioactive molecules and how their popularity has evolved over time","volume":"63","author":"Ertl","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119225_bib26","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41573-022-00472-w","article-title":"Phenotypic drug discovery: recent successes, lessons learned and new directions","volume":"21","author":"Vincent","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119225_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ejmech.2012.09.036","article-title":"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9","volume":"58","author":"Nicolotti","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119225_bib28","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1039\/C9QO00421A","article-title":"Iminyl radical-promoted imino sulfonylation, imino cyanogenation and imino thiocyanation of \u03b3,\u03b4-unsaturated oxime esters: synthesis of versatile functionalized pyrrolines","volume":"6","author":"Wang","year":"2019","journal-title":"Org. Chem. Front."},{"key":"10.1016\/j.ejmech.2026.119225_bib29","doi-asserted-by":"crossref","first-page":"23690","DOI":"10.1021\/acs.jmedchem.5c02076","article-title":"Lipophilic cations as mitochondria-targeting moieties: recent progress and design principles for medicinal chemistry","volume":"68","author":"D\u017eaji\u0107","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119225_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2023.151371","article-title":"MitoTracker: a useful tool in need of better alternatives","volume":"102","author":"Neikirk","year":"2023","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119225_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","article-title":"Mitochondrial membrane potential","volume":"552","author":"Zorova","year":"2018","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2026.119225_bib32","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1073\/pnas.88.9.3671","article-title":"Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1","volume":"88","author":"Smiley","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2026.119225_bib33","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejmech.2026.119225_bib34","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41556-024-01429-4","article-title":"Mitochondria and cell death","volume":"26","author":"Glover","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119225_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33665","article-title":"Flow cytometry-based quantitative analysis of cellular protein expression in apoptosis subpopulations: a protocol","volume":"10","author":"Alshehade","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2026.119225_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fcell.2019.00355","article-title":"Mitochondrial involvement in migration, invasion and metastasis","volume":"7","author":"Denisenko","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2026.119225_bib37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2016.03.013","article-title":"Three-dimensional culture systems in cancer research: focus on tumor spheroid model","volume":"163","author":"Nath","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.119225_bib38","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.3390\/ijms21176225","article-title":"Spheroids as a type of three-dimensional cell Cultures\u2014Examples of methods of preparation and the most important application","volume":"21","author":"Bia\u0142kowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119225_bib39","doi-asserted-by":"crossref","first-page":"18826","DOI":"10.1039\/D5CC04649A","article-title":"Metal- and photocatalyst-free benzylic C-H halogenation via an electron donor-acceptor complex","volume":"61","author":"Cao","year":"2025","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.119225_bib40","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1039\/b700215g","article-title":"Poly(vinyl alcohol)-graft-poly(ethylene glycol) resins and their use in solid-phase synthesis and supported TEMPO catalysis","volume":"43","author":"Luo","year":"2007","journal-title":"Chem. Commun."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:00:36Z","timestamp":1793977236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426006707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":40,"alternative-id":["S0223523426006707"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119225","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of mitochondria-targeted isoquinolinium derivatives with dual fluorescence and anticancer activity against KRAS-mutant NSCLC","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119225"}}